Tag Archives: neurological diseases

December, 2018

April, 2018

March, 2017

  • 17 March

    AveXis’ Gene Therapy for SMA Demonstrates Positive Results

    CHICAGO, March 16, 2017 (GLOBE NEWSWIRE) — AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today reported topline results from the Phase 1 trial of AVXS-101 in spinal muscular atrophy (SMA) Type 1. The company also reported financial …

January, 2017

  • 18 January

    Takeda and Ovid Partner for Development of Rare Pediatric Epilepsy Drug

    OSAKA, Japan & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) and Ovid Therapeutics Inc., a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the formation of a global collaboration focused on the clinical development and commercialization of Takeda’s …

April, 2015